| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |